Quantcast

Latest diarrhea Stories

fecal pills
2014-10-14 03:00:49

Provided by Noah Brown, The JAMA Network Journals A preliminary study has shown the potential of treating recurrent Clostridium difficile infection (a bacterium that is one of the most common causes of infection of the colon) with oral administration of frozen encapsulated fecal material from unrelated donors, which resulted in an overall rate of resolution of diarrhea of 90 percent, according to a study published in JAMA. The study is being released early online to coincide with its...

2014-10-09 12:28:58

Results for groundbreaking multi-center study of lead drug candidate RBX2660 (microbiota suspension) presented at IDWeek 2014 PHILADELPHIA, Oct. 9, 2014 /PRNewswire/ -- Rebiotix Inc. announced today that results of the Phase 2 PUNCH(TM) CD Study found that the overall efficacy of RBX2660 in the treatment of recurrent Clostridium difficile infection was 87.1%. The study also found that administration of RBX2660 was well-tolerated and demonstrated satisfactory safety in the 60-day...

2014-10-07 08:28:36

Ninety-four per cent of Canadians are unaware they can get sick from contaminated ice cubes while on vacation(1) TORONTO, Oct. 7, 2014 /CNW/ - Planning for warmer climates this travel season? Why spoil the fun? Up to 70 per cent of travellers may experience travellers' diarrhea while on vacation, the most common travel-related disease. However, a recent survey has revealed the majority of Canadians (79%) are not as travel savvy as they should be about the potential causes, symptoms and risks...

2014-10-02 08:29:52

First rapid test to distinguish between pathogenic and non-pathogenic species WALTHAM, Mass., Oct. 2, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, announced today that the new E. HISTOLYTICA QUIK CHEK(TM) test, which identifies the Entamoeba histolytica parasite, has received CE Mark for sale in international markets outside of the United States. The test is developed and manufactured by TECHLAB(®) Inc. Entamoeba histolytica is an intestinal...

2014-10-01 12:31:15

Rebiotix lead drug candidate RBX2660 (microbiota suspension) assessed in PUNCH CD study ROSEVILLE, Minn., Oct. 1, 2014 /PRNewswire/ -- Rebiotix Inc. announced this morning that results of PUNCH CD, a Phase 2 study of the company's lead product candidate, RBX2660 (microbiota suspension), will be presented in three posters at the American College of Gastroenterology (ACG) Annual Scientific Meeting in Philadelphia from October 17-22. The following poster will be presented on Monday, October 20,...

2014-09-23 12:29:47

CHICAGO, Sept. 23, 2014 /PRNewswire-USNewswire/ -- C Diff Foundation is proud to present the 2014 "Raising C.difficile Awareness" conference. Join us November 4(th) at 8 a.m. - 5 p.m. at the University of Illinois at Chicago, Student Center, West 828 S. Wolcott Avenue, Thompson Room, Chicago, IL. World renowned topic experts will be presenting data for C. difficile and Hospital-Acquired Infection (HAI) prevention, treatments, and environmental safety. To view the conference details,...

2014-09-23 04:21:56

OxThera AB announced today that its product Oxabact® has been granted an Orphan Drug Designation in the European Union for treatment of Short Bowel Syndrome (SBS) STOCKHOLM, September 23, 2014 /PRNewswire/ -- SBS is a highly disabling malabsorptive condition. SBS is associated with significant morbidity and mortality, reduced quality of life and high healthcare costs. "We are happy to announce that Oxabact(R) is now also recognized as a potential treatment for Short...

2014-09-19 12:25:43

DUBLIN, Sept. 19, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 For the purposes of this report, the human microbiome market is segmented by application, disease, product, and geography. The human microbiome market is expected to be valued as $294 million in 2019 and...

2014-09-17 12:27:55

Rebiotix microbiota-based drug candidate used to assess a non-antibiotic approach to an urgent public health threat ROSEVILLE, Minn., Sept. 17, 2014 /PRNewswire/ -- Rebiotix Inc. announced this morning that results of the Phase 2 study of the company's lead product candidate, RBX2660 (microbiota suspension) will be presented in two posters and a podium presentation during the IDWeek 2014 conference in Philadelphia from October 8-12. PUNCH CD study results will be presented during the poster...

2014-09-11 08:27:38

-- Conference Call Scheduled for Friday, September 12, 2014, at 9:15 a.m. EDT -- ROCKVILLE, Md., Sept. 11, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it will host a an investor conference call on Friday, September 12, 2014, at 9:15 a.m. EDT. The conference call will highlight...


Latest diarrhea Reference Libraries

0_9f897835bb09adc2a84fda23893d87f8
2011-04-15 13:50:01

Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...

11_f79bc6a70a3ca6d0849bbfc3e310d871
2011-02-23 20:42:46

Rotavirus is the most common cause of diarrhea among infants and young children and is one of several viruses that cause the stomach flu. It is in the family Reoviridae and is a genus of double-stranded RNA. Most children have been infected by the age of five. Each infection builds on previous immunity and thus subsequent infections are less severe and adults are rarely affected. The fives species of the virus are referred to as A, B, C, D, and E. Type A, which is the most common, causes more...

45_7b9aa20b6263a73b7fcd4e869f868330
2011-02-17 17:29:15

Norovirus is an RNA virus that causes approximately 90% of epidemic non-bacterial outbreaks of gastroenteritis around the world. It may also be responsible for 50% of all foodborne outbreaks of gastroenteritis in the U.S. It can affect people of all ages and is transmitted by food or water that is contaminated, by person-to-person contact, and through aerosolization of the virus and subsequent contamination of surfaces. Immunity is usually incomplete and temporary after infection. People...

More Articles (3 articles) »
Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin